• Date of issue: November 2016
  • Delivery: PDF

OTC market in the Czech Republic 2016

Market analysis and development forecasts for 2016-2021

This comprehensive report delivers up-to-date value and growth data and incisive analysis of the powerful trends observed on the OTC (over-the-counter) market in the Czech Republic. It provides information describing consumer preferences, bestselling OTC medicines and dietary supplements, the legal and regulatory environment, and expert predictions for market growth and sales totals in each main therapeutic category. A look at the future of the market is possible through detailed development forecasts (total market as well as each of the largest categories) for 2016-2021.
 

What is the content of PMR’s report on the OTC market in the Czech Republic?

 
  • Data representing recent and current market value, growth and sales by therapeutic categories
  • Predictions for future growth in the OTC market in the Czech Republic from 2016 to 2021
  • Leading OTC medicines and dietary supplements manufacturing companies participating on the market in the Czech Republic
  • Advertising activities of pharmaceutical companies
  • Top-selling OTC medicines and dietary supplements in the Czech Republic
  • Influence of consumer behaviour and preferences, as well as recent and anticipated events and trends on the OTC market value assessed by experienced PMR analysts  
  • Data and analysis of current market conditions in the pharmacy, non-pharmacy and online retail segments of the market
  • Saturation level for the national over-the-counter drugs market
  • Pharmaceutical market share claimed by OTC products on this market
  • Historical data that enables readers to track recent development of the market and its segments
  • Regulations with the most impact on this market and rules to be implemented in the near future.
 

Who benefits from the analysis? 

 
Reach for the report if you work as a marketing, sales or business development expert at:
  • Company that manufacture OTC medicines, dietary supplements and well as other OTC products
  • Wholesaler and retailer (pharmacy and non-pharmacy) companies, or online stores offering medicines and OTC products
  • Importer of OTC products
  • Advertising agency involved in the promotion of pharmaceuticals
  • Financial institution or bank investing in pharma markets
  • Academic, business research and consulting firms
  • Government office and embassy.
 

Why to buy the report? 

 
Consult the report when searching for recent events, expert comments, regulatory environment and development forecasts for the OTC market in the Czech Republic, including the following processes:
  • Monitoring the market situation and growth prospects
  • Assessing the impact of recent and anticipated trends and events on the sales of the company
  • Budgeting and planning expenses for the company or a specific project
  • Transforming current growth strategy on the OTC and dietary supplements market in the Czech Republic
  • Building market entry strategy for the sector and country
  • Conducting an analysis of the competitive environment on the national pharmaceuticals market.
 

Report updates 

 
For an additional price, PMR also offers packages that include updates of this report: “Report + 1 Update” or “Report + 2 Updates”. The above-mentioned packages are only available for purchase directly from PMR sales consultants at: sales@pmrcorporate.com / tel. +48 12 3405130.
 
The packages are dedicated to clients who need market information refreshed more often than once a year. The report and its updates are published within one year. They provide the most current data and expert commentaries. The revised indices, statistics and information will be valuable for the purposes of budgeting, strategic planning and market monitoring.
 
As a London-based company, with operations abroad, we looked for the best-in-class Market Intelligence supplier. PMR brought us quality reports that improved our CEE market knowledge and understanding. Development Manager, GVA Grimley
PMR provides a good service and is always open to discussion. All reports are well structured & are always on time. Member of the Managment Board, SCA Hygiene Products
We use PMR's services due to their analysts' extensive experience in market analysis, their high quality and level of engagement in the market research carried out for us. We consider PMR a competent and professional company and recommend them as a reliable partner in the area of economic information and market analysis. Senior Trade and Investment Adviser, British Embassy in Warsaw
PMR reports are a serious contribution to the market overview picture, focusing our attention on key events in the industry as well as highlighting both general and specific market indicators. Together, these components are the base for our future forecasts of construction market development and help us to plan our sales. Market Analyst, Alpha Cement
It's a great pleasure to cooperate with PMR because of its analysts' wealth of experience in understanding the local market. We consider PMR a competent and professional company which helps us conduct our business. I would also like to state that PMR's team is always ready to respond to emerging customer needs. We can recommend it as a reliable partner. Business Analyst, Hilti Distribution, Russia
PMR's analysts understand our needs well and the standard of their service has always fully met our expectations. We are looking forward to cooperating with PMR in the future as well. Senior Trade and Investment Adviser, British Embassy in Warsaw

  • Methodology
  • Executive summary
  • Overview of the OTC market in the Czech Republic
    • Main trends and events on the OTC market
    • OTC market value
      • OTC market value by distribution channel
      • OTC market value by product status (drugs vs dietary supplements)
      • Share of OTC products as a proportion of the pharmaceutical market
      • Value of the OTC product market between 2008 and 2020
      • Volume of the OTC products market
      • Value of the dietary supplement market
      • Volume of the dietary supplements market
      • OTC product market by therapeutic categories
    • Prices of OTC products
      • OTC drugs
      • Dietary supplements
    • Switch from Rx to OTC
    • Bestselling OTC products
      • By value
      • By volume
    • Advertising
      • Legal framework
      • Spending on OTC advertising
    • Key players
      • Important events pertaining to companies present on the market
  • Profiles of selected manufacturers on the OTC market in CE
    • Bayer HealthCare
      • General information
      • Financial results
      • Product portfolio
      • Market strategy and OTC sales in CE
    • Berlin-Chemie/Menarini
      • General information
      • Financial results
      • Product portfolio
      • Market strategy and OTC sales in CE
    • GlaxoSmithKline
      • General information
      • Financial results
      • Product portfolio
      • Market strategy and OTC sales in CE
    • Krka
      • General information
      • Financial results
      • Product portfolio
      • Market strategy and OTC sales in CE
    • Polpharma
      • General information
      • Financial results
      • Market strategy and OTC sales in CE
    • Sanofi
      • General information
      • Financial results
      • Product portfolio
      • Market strategy and OTC sales in CE
    • Sopharma
      • General information
      • Financial results
      • Product portfolio
      • Market strategy and OTC sales in CE
    • Teva
      • General information
      • Financial results
      • Product portfolio
      • Market strategy and OTC sales in CE
    • US Pharmacia
      • General information
      • Finacial results
      • Product portfolio
      • Market strategy and OTC sales in CE
    • Walmark
      • General information
      • Product portfolio
      • Market strategy and OTC sales in CE

Graphs

  • Categories of cosmetics bought by Czechs at pharmacies (%), 2015
  • Reasons for buying cosmetics at pharmacies in the Czech Republic (%), 2015
  • Number of dietary supplements in the Czech Republic of which launch the National Institute of Public Health was notified and change (%), 2007 – Jan-Oct 2015
  • Percentage of people purchasing OTC products for allergies and atopic dermatitis at pharmacies in the Czech Republic (%), February 2016
  • Source of advice among Czechs who purchase allergy and atopic dermatitis treatment medicines at pharmacies (%), February 2016
  • Source of advice among Czechs who purchase other OTC allergy and atopic dermatitis products at pharmacies (%), February 2016
  • Proportion of overweight male population in 15 most prominent countries, 2030
  • Places at which OTCs are purchased by Czechs (%), 2016
  • Category of pharmaceutical and parapharmaceutical products most frequently bought online in the Czech Republic (%), 2014
  • Category of pharmaceutical and parapharmaceutical products most frequently bought online in the Czech Republic (%), 2015
  • Share of OTC drugs and dietary supplements as a proportion of sales value of pharmacies in the Czech Republic (%), by category of pharmacy, November 2014-October 2015
  • Share of OTC drugs and dietary supplements as a proportion of the OTC pharmacy product market in the Czech Republic (%), by value, 2010-2014
  • Share of OTC drugs and dietary supplements as a proportion of the OTC pharmacy product market in the Czech Republic (%), by volume, 2007, 2009, 2011 and 2014
  • Share of OTC drugs and dietary supplements as a proportion of the Czech pharmaceutical market (%), pharmacy sales, by value, 2014
  • Share of OTC drugs and dietary supplements as a proportion of the Czech pharmaceutical market (%), by value, 2015
  • Share of OTC drugs and dietary supplements as a proportion of the Czech pharmaceutical market (%), pharmacy sales, by volume, September 2013-August 2014
  • Value (CZK bn) and change (%, y-o-y) of the OTC product market in the Czech Republic, 2008-2021
  • Number of packets of OTC drugs sold in the Czech Republic (million) and change (%), 2009 - Q1-Q3 2015
  • Value (CZK bn) and change (%, y-o-y) of the dietary supplement pharmacy market in the Czech Republic, 2010-2021
  • Volume of the dietary supplement pharmacy market in the Czech Republic (million packets), 2007, 2011 and 2015
  • Y-o-y change in the OTC product categories in the Czech Republic (%), by value, November 2014-October 2015
  • Average price per OTC packet in the Czech Republic (CZK), March 2014-February 2015 and March 2015-February 2016
  • Average manufacturer price per packet of OTC drugs in the Czech Republic (CZK) and change (%), 2009-2015
  • Average manufacturer price per dietary supplement packet in the Czech Republic (CZK), 2007-2011 and 2014
  • Spending on advertising of pharmaceuticals for colds, coughs and flu in the Czech Republic (CZK m), October 2015-March 2016
  • Spending on pharmaceutical product internet advertising in the Czech Republic (CZK m) and y-o-y change (%), 2013-H1 2016
  • Krka Group employment breakdown (%), by regions, 2015
  • Krka's sales of OTC products in selected CE countries (€ m), 2011-2015
  • Increases in Krka's OTC sales in selected CE countries (%), H1 2016
  • Krka’s global revenues and net profit (€ m), 2005-H1 2016
  • Share of new products as a proportion of Krka’s total sales value (%), 2009-2015
  • Krka’s global revenues from OTC products (€ m) and y-o-y change (%), 2011-H1 2016
  • Share of Krka sales as a proportion of the total global market, by region (%), 2014-H1 2016
  • Krka’s sales in CE countries analysed (€ m), 2013-H1 2016
  • Krka’s global OTC sales (%), by product groups, 2015
  • Revenues and net profit of Zaklady Farmaceutyczne Polpharma SA (€ m), 2007 – Q1-Q3 2015
  • Revenues and net profit of Polpharma Biuro Handlowe Sp. z o.o. (PLN m), 2008-2014
  • Revenues and net profit of Warszawskie Zaklady Farmaceutyczne Polfa SA (PLN m), 2008 – Q1-Q3 2015
  • Revenues and net profit of Medana Pharma SA (PLN m), 2008-2014
  • Product structure for Polpharma in Poland, by number of products in specific categories (%), May 2016
  • Product structure for Polfa Warszawa in Poland, by number of products in specific categories (%), May 2016
  • Sopharma global revenues and net profit (€ m), 2008-H1 2016
  • Sopharma AD sales revenues and net profit (€ m), 2013-2015
  • Sopharma AD global revenues (€ m), by geographical market, 2013-H1 2016
  • Sopharma AD sales revenues, by country and region (%), 2014-H1 2016
  • USP Zdrowie revenue and net profit (€ m), 2011-2014
  • US Pharmacia revenue and net profit (€ m), 2009-2014
  • Product structure for USP Zdrowie/US Pharmacia in Poland, by number of products in specific categories (%), May 2016
  • Walmark sales revenues in Poland (€ m) and change (%, y-o-y), 2008/2009-2014/2015
  • Walmark sales revenues in Hungary (€ m) and change (%, y-o-y), 2009/2010-2014/2015
  • Walmark’s sales revenues in Romania (€ m) and change (%, y-o-y), 2010-2015
  • Walmark a.s. revenues (€ m) and change (%, y-o-y), 2011/2012-2014/2015
  • Walmark sales revenues in Bulgaria (€ m) and change (%, y-o-y), 2008-2014
  • Walmark sales revenues in Slovakia (€ m) and change (%, y-o-y), 2010/2011-2014/2015

Tables

  • Main past events and trends, and their effect on the OTC market in the Czech Republic, 2014-2016
  • Opinions pertaining to flu vaccinations among women and men in the Czech Republic (%), October 2015
  • Frequency of consumption of immune system preparations among Czechs, by sex (%), December 2015
  • Frequency of consumption of immune system preparations among Czechs, by age (%), December 2015
  • Purchases of drugs for colds, coughs, colds and flu among Czechs, based on personal opinion or pharmacist's recommendation, by sex (%), December 2015
  • Number of OTCs and homeopathic drugs (SUKL codes) registered with and cleared for trade by the SUKL in the Czech Republic, 2011-2015
  • Number of OTCs and homeopathic drugs (MA numbers) registered with and cleared for trade by the SUKL in the Czech Republic, 2011-2015
  • Anticipated trends and events, and their effect on the OTC market in the Czech Republic, 2016-2030
  • Places at which OTCs are purchased by Czechs (%), with frequency, 2016
  • Places at which dietary supplements are purchased by Czechs (%), 2016
  • Places at which dietary supplements are purchased by Czechs (%), with frequency, 2016
  • Frequency of purchase of medicines online in the Czech Republic (%), 2011-2015
  • Number of packets of OTCs sold in the Czech Republic (million) and change (%), September 2015-August 2016
  • OTC market in the Czech Republic, by main product categories (CZK bn), 2012-2021
  • Sales, y-o-y change and market share in the OTC product categories in the Czech Republic, by value (CZK bn), January-September 2015
  • Average price per packet of selected bestselling OTC drugs in the Czech Republic (CZK), 2015
  • Selected changes in medicinal status (Rx to OTC switch) in the Czech Republic, 2015-August 2016
  • Selected 10 bestselling OTC drugs in the Czech Republic, by value (CZK m), 2015
  • Selected 10 bestselling OTC drugs in the Czech Republic, by value (CZK m), Q1 2016
  • Selected 9 bestselling OTC drugs in the Czech Republic, by value (CZK m), Q2 2016
  • Bestselling 15 OTC drugs in the Czech Republic, wholesale sales, by volume (‘000 packets), 2015
  • OTC products most often recommended by pharmacists in the Czech Republic in selected product categories (%), 2015
  • Bestselling OTC products in parallel trade sector in the Czech Republic, 2014/2015
  • Bestselling 10 OTC drugs in the Czech Republic, by volume (‘000 packets), Q1 2016
  • Bestselling 9 OTC drugs in the Czech Republic, by volume (‘000 packets), Q2 2016
  • Spending on pharmaceutical product advertising in the Czech Republic (CZK m) and y-o-y change (%), 2014-2015
  • Top 10 manufacturers of OTC drugs in the Czech Republic, by value (CZK bn), 2015
  • Top 10 manufacturers of OTC drugs in the Czech Republic, by value (CZK bn), H1 2016
  • Top 10 manufacturers of OTC drugs in the Czech Republic, by volume (million packets), 2015
  • Top 10 manufacturers of OTC drugs in the Czech Republic, by volume (million packets), H1 2016
  • General information pertaining to Bayer HealthCare, 2016
  • Companies belonging to Bayer in CE countries analysed, 2016
  • Sales of individual Bayer companies registered in selected CE countries (€ m), 2015
  • General information pertaining to Bayer’s product portfolio, 2015
  • General information pertaining to Berlin-Chemie/Menarini, 2015
  • Sales of individual Berlin-Chemie/Menarini companies registered in selected CE countries (€ m), 2015
  • General information pertaining to Berlin-Chemie/Menarini’s product portfolio, 2016
  • General information pertaining to GlaxoSmithKline, 2016
  • Companies belonging to GSK in CE countries analysed, 2016
  • Sales of individual GSK companies registered in selected CE countries (€ m), 2013, 2014 or 2015
  • General information pertaining to GSK’s product portfolio, 2016
  • Selected GSK’s OTC products with the highest advertising spending in Poland (PLN m), January-May 2016
  • General information pertaining to Krka, 2016
  • Ownership structure of Krka (%), 2016
  • Companies belonging to Krka in CE countries analysed, 2016
  • Structure of Krka in CE countries analysed, 2015
  • Sales of individual Krka companies registered in selected CE countries (€ m), 2013 or 2015
  • Krka’s sales breakdown, by product or category of service (€ m) and change (y-o-y, %), 2014-H1 2016
  • Krka’s global sales (€ m), by region, 2012-H1 2016
  • General information pertaining to Krka’s product portfolio in CE countries analysed, H1 2016
  • General information pertaining to sales of Krka OTC products in Poland, 2015-H1 2016
  • General information pertaining to sales of Krka OTC products in Hungary, 2015-H1 2016
  • General information pertaining to sales of Krka’s OTC products in Romania, 2015-H1 2016
  • General information pertaining to sales of Krka’s OTC products in the Czech Republic, 2015-H1 2016
  • General information pertaining to sales of Krka’s OTC products in Bulgaria, 2015
  • General information pertaining to sales of Krka’s OTC products in Slovakia, 2015-H1 2015
  • General information about Polpharma Group in Poland, 2016
  • Ownership structure of Polpharma Group in Poland, 2016
  • Selected Polpharma’s OTC products with the highest advertising spending in Poland (PLN m), January-May 2016
  • Polpharma Group’s planned and ongoing investments in its facilities in Poland, 2016
  • General information pertaining to Sanofi, 2016
  • Companies belonging to Sanofi in CE countries analysed, 2016
  • Sales of individual Sanofi companies registered in selected CE countries (€ m), 2014 or 2015
  • General information pertaining to Sanofi’s product portfolio, 2015
  • General information pertaining to Sopharma, Q1 2016
  • Ownership structure of Sopharma AD (%), 30 June 2016
  • Selected companies in Sopharma Group in CE countries analysed, Q2 2016
  • Total area (m²), capacity and number of employees at selected Sopharma manufacturing plants in Bulgaria, 2015
  • Sopharma Group sales revenues from goods, by pharmaceutical form (%), H1 2016
  • Sopharma Group sales revenues from finished products, by pharmaceutical form (%), H1 2016
  • General information pertaining to Sopharma product portfolio, 2014
  • General information pertaining to Teva, 2016
  • Sales of individual Teva companies registered in selected CE countries (€ m), 2014 or 2015
  • General information pertaining to Teva’s product portfolio, 2015
  • General information pertaining to US Pharmacia/USP Zdrowie, 2016
  • Ownership structure of USP Zdrowie in Poland (%), 2016
  • General information pertaining to USP Zdrowie product portfolio, 2016
  • Selected USP Zdrowie’s OTC products with the highest advertising spending in Poland (PLN m), January-May 2016
  • General information pertaining to Walmark, 2016
  • Ownership structure of Walmark (%), 2016
  • Structure of Walmark in CE countries analysed, 2016
  • General information pertaining to Walmark’s product portfolio, 2014
  • Leading Walmark’s dietary supplement brands in Central Europe, 2015
  • General information pertaining to sales of Walmark OTC products in Poland, October 2016
  • General information pertaining to sales of Walmark OTC products in Hungary, October 2016
  • General information pertaining to sales of Walmark’s OTC products in Romania, 2016
  • General information pertaining to sales of Walmark OTC products in the Czech Republic, 2016
  • General information pertaining to sales of Walmark OTC products in Bulgaria, 2015
  • General information pertaining to sales of Walmark OTC products in Slovakia, 2016